Three-year outcomes of tumor necrosis factor alpha inhibitor therapy in rheumatoid arthritis patients with elevated liver enzymes

Table 1 Baseline characteristics of the patients, n (%)

Characteristics	Study participants (n = 9)
Age (years)	56 (49.5-64.5)
Females	7 (77.8)
Hispanic	9 (100)
Body mass index (kg/m2)	36.99 (30.95-43.43)
Comorbidities
Hypertension	4 (44.4)
Type 2 diabetes mellitus	1 (11.1)
Fatty liver	1 (11.1)
Low disease activity	1 (11.1)
Moderate disease activity	7 (77.8)
High disease activity	1 (11.1)
Medications
Statins	3 (33.3)
Methotrexate	7 (77.8)
Leflunomide	3 (33.3)
Sulfasalazine	2 (22.2)
Steroids	6 (66.7)
Non-steroidal anti-inflammatory drugs	8 (88.9)

Values are reported as median (interquartile range) or n (%).